Holista CollTech Ltd
ASX:HCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Holista CollTech Ltd
Short-Term Debt
Holista CollTech Ltd
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Holista CollTech Ltd
ASX:HCT
|
Short-Term Debt
AU$1.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Bioxyne Ltd
ASX:BXN
|
Short-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Skin Elements Ltd
ASX:SKN
|
Short-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
McPherson's Ltd
ASX:MCP
|
Short-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Short-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Short-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Holista CollTech Ltd
Glance View
Holista CollTech Ltd. engages in the research, development, manufacture, and marketing of natural ingredients and wellness products. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2004-02-26. The firm is focused on researching, developing, manufacturing, and marketing health-style products. The firm's segments include Supplements, Ovine collagen, Food ingredients, and Infection control. The Supplements segment is engaged in the manufacture and wholesale distribution of dietary supplements. Ovine collagen is engaged in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is engaged in the manufacture and wholesale distribution of healthy food ingredients. Infection control segment is engaged in the infection control solutions. Its Path-Away technology is developed from bioflavonoids, which kill approximately 170 viruses, bacteria and fungi-naturally and without side effects. The firm's products include M3 System, FogClean, OVICOLL 98, OVICOLL 95, OVINEX and GILite.
See Also
What is Holista CollTech Ltd's Short-Term Debt?
Short-Term Debt
1.1m
AUD
Based on the financial report for Dec 31, 2025, Holista CollTech Ltd's Short-Term Debt amounts to 1.1m AUD.
What is Holista CollTech Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 5Y
25%
Over the last year, the Short-Term Debt growth was -12%. The average annual Short-Term Debt growth rates for Holista CollTech Ltd have been 36% over the past three years , 25% over the past five years .
